Aerosolized platinum nanoparticle chemotherapy for lung cancer
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA203142
- Recipient
-
Hylapharm LLC UEI D78KUMZNMEL5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $298,065
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Lawrence, KS 66047, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $298,065 |
Quick answers
Who received award R43CA203142?
R43CA203142 was awarded to Hylapharm LLC by National Cancer Institute (National Institutes of Health) on February 1, 2017.
How much is award R43CA203142 worth?
$298,065 has been obligated on R43CA203142.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award